摘要
癌性贫血是单因素或多因素共同作用的结果,这些因素包括慢性病贫血、肿瘤引起的出血、溶血、骨髓浸润、营养不良、放化疗引起的骨髓抑制等。由于全球老龄化趋势及各种致癌相关因素的存在,导致恶性肿瘤的发病率持续升高,癌性贫血更为凸显。既往欧洲癌症贫血调查（european cancer anemia survey,ECAS）显示肿瘤患者贫血发病率为39.3%（Hb〈120g/L）,
Summary Cancer related anemia is a kind of diseased which belongs to anemia of chronic disease. With the advance of medical technology and treatment technique, the lifetime and life quality are trend to increase by year. Anemia, as the most common complication during the treatment of malignant tumors, not only obviously decreases the life quality of tumor patients, but also to some extent to affect the application and results of many therapeutic methods. So how to improve the cancer related anemia becomes to be hot topic of many researchers. Erythrocyte transfusion is a common method to solve the cancer relative anemia. But invalid erythrocyte transfusion usually happened and was ignored by many clinical doctors because it would not result obvious clinical symptoms. To efficiently utilize blood resource and avoid delaying the treatment and aggravating financial burden in patients, methods must be found to avoid the occurrence of invalid erythrocyte transfusion.
出处
《临床血液学杂志（输血与检验）》
CAS
2016年第5期848-851,共4页
Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词
恶性肿瘤
癌性贫血
红细胞
输注无效
malignant tumors cancer related anemias erythrocyte
invalid transfusion
